Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03433911 · ClinicalTrials.gov registry record · NA
FemBloc® Permanent Contraception - Early Pivotal Trial
A NA study of Contraception, sponsored by Femasys.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 12
- Study locations
NCT03433911 is a NA study of Contraception that has completed, run by Femasys. The registered enrollment target is 240 participants, below the 451-participant average among 72 other Contraception trials with a reported enrollment target (47% lower). The trial reports 12 study locations across 11 states.
The verdict
NCT03433911, a NA study of Contraception, has completed, sponsored by Femasys.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 12
- Study locations
Study Summary
Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The FemBloc group total study duration will be approximately 65 months. The laparoscopic tubal sterilization (Control) group total study duration will be approximately 62 months.
Conditions Studied
Interventions
- DEVICE FemBloc
- PROCEDURE Laparoscopic bilateral tubal sterilization
Study Locations (12)
Ohio
- University Hospitals Cleveland Medical Center - Beachwood
- Amy Brenner MD & Associates - Mason
Arizona
- New Horizons Clinical Trials - Chandler
California
- Stanford University - Stanford
Florida
- Altus Research Inc. - Lake Worth
Idaho
- Rosemark Womencare Specialists - Idaho Falls
Indiana
- Women's Health Advantage - Fort Wayne
New Jersey
- Rutgers, The State University of New Jersey - Newark
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2018-02-02 |
| Est. Completion | 2025-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03433911
The ClinicalTrials.gov registry entry for NCT03433911 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 451-participant average among 72 other Contraception trials with a reported enrollment target (47% lower). The listed sponsor is Femasys, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 2 interventions - of which FemBloc is the first listed.
NCT03433911 reports 12 study locations spanning 11 distinct geographic areas - top geographies include Ohio, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT03433911 about?
NCT03433911 is a clinical study titled "FemBloc® Permanent Contraception - Early Pivotal Trial". Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The FemBloc group total study duration will be approximately 65 months. The laparoscopic tubal sterilization (Control) group total st...
What is the current status of trial NCT03433911?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2018-02-02. Estimated completion is 2025-02-10.
What conditions does trial NCT03433911 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT03433911?
The interventions under investigation include: FemBloc (DEVICE), Laparoscopic bilateral tubal sterilization (PROCEDURE).
Who is sponsoring clinical trial NCT03433911?
This trial is sponsored by Femasys, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03433911 being conducted?
This trial has 12 study locations across Arizona, California, Florida, Idaho, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.